Navigation Links
Boston Scientific Announces Schedule for ACC 2008
Date:3/25/2008

NATICK, Mass., March 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for Cardiovascular Angiography and Interventions SCAI Annual Scientific Sessions in Partnership with the American College of Cardiology ACC/i2 Summit, which runs from March 29 to April 1 in Chicago.

"Clinical data presented at ACC for the TAXUS(R) paclitaxel-eluting coronary stent will report on outcomes in a variety of high-risk patient populations," said Paul LaViolette, Chief Operating Officer of Boston Scientific. "We expect results will show continued positive data for the TAXUS Stents in these complex patients and lesions."

Schedule of Events (all times are Central Time)

Saturday, March 29

-- ARRIVE Diabetic Analysis. D. Lynn Morris, M.D., will present one-year

outcomes from a pooled analysis of the ARRIVE 1 & 2 Registries,

including subset data for 4,772 patients, including 1,530 diabetics.

The ARRIVE program is designed to collect and analyze "real-world"

safety and clinical outcomes data for the TAXUS(R) Express2(TM)

paclitaxel-eluting stent system in the treatment of patients with

coronary artery disease. The diabetic sub-group analysis is designed

to evaluate clinical restenosis in diabetic patients and non-diabetics

treated with the TAXUS Express2 Stent. The results will be presented

at 8:00 a.m., during an e-poster session. The Company plans to issue a

press release at this time.

-- ARRIVE High-Risk Patient Analysis. John M. Lasala, M.D., will present

two-year data from 7,307 high-risk patients in t
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
2. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
3. Life Science Industry Awards to Be Announced June 3, 2008 in Boston
4. Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
5. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
6. Boston Scientific to Participate in Lehman Brothers Health Care Conference
7. Boston Scientific Announces European Approval of New Heart Failure Lead
8. BioSpace Boston Career Fair Attracts over 900 Bioscience Candidates
9. Boston Scientific Announces Addition to Clinical Sciences Organization
10. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
11. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... September 22, 2014 Research ... addition of the "Global Biotechnology Reagents Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are ... a system to detect and examine another substance ... used in laboratories to prepare, collect, and examine ...
(Date:9/22/2014)... have generated a new star-shaped molecule made up of interlocking ... created. , Known as a ,Star of David, ... a quarter of a century and the team,s findings are ... Consisting of two molecular triangles, entwined about each other three ... each triangle is 114 atoms in length around the ...
(Date:9/22/2014)... This is a professional and in-depth ... industry in Global and China. The report provides ... and industry chain structure. Global market analysis and Chinese ... history, developments, trends and competitive landscape of the market. ... also offered. , The report also focuses on development ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 ... primal desire to stay young has groomed and ... dollar industry worldwide. Growing emphasis on appearance maintenance ... Toxin is a neurotoxic protein obtained from the ... acetylcholine, resulting in muscle relaxation. With cosmetic indications ...
Breaking Biology Technology:Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3
... Mass., March 19 MacroChem,Corporation (OTC Bulletin Board: ... to the position of Chief Financial Officer, effective,immediately. ... and Vice,President, Corporate Development since joining the Company ... CFO of Bioenvision, Inc. prior to its,successful merger ...
... Years In 2008 And, Beyond, According To The Latest Research Released By ... ... the economy slides into,recession, IBISWorld today announced its list of industries with ... of the top 10 industries which IBISWorld predicts to do,well in 2008 ...
... of Standards and Technology (NIST) have set the stage ... today built from semiconductor compounds and future generations of ... upcoming paper in the Journal of the American Chemical ... of organic molecules can be assembled on the same ...
Cached Biology Technology:MacroChem Appoints David P. Luci as New CFO 2MacroChem Appoints David P. Luci as New CFO 3The Recession List - Top 10 Industries to Fly and Flop in 2008 2The Recession List - Top 10 Industries to Fly and Flop in 2008 3The Recession List - Top 10 Industries to Fly and Flop in 2008 4The Recession List - Top 10 Industries to Fly and Flop in 2008 5The Recession List - Top 10 Industries to Fly and Flop in 2008 6NIST team proves bridge from conventional to molecular electronics possible 2
(Date:9/23/2014)... -- Newest Market IPO,s and exchange ... significant investor attention with news concerning shareholder updates and new ... NXT-ID, Inc. (NASDAQ: NXTD ), Alibaba Group Holding ... MBLY ), GoPro, Inc. (NASDAQ: GPRO ) ... (NASDAQ: NXTD ) recently completed an essential round ...
(Date:9/22/2014)... ATLANTA September 23, 2014 A new American ... Supplemental Nutrition Assistance Program (SNAP), previously known as ... scores compared with income eligible non-participants. The authors ... programs aimed at enhancing the dietary quality of ... assist low-income individuals and households with the resources ...
(Date:9/22/2014)... genetic sequencing technologies continue to evolve rapidly, becoming part ... establish appropriate policies and regulatory frameworks to address potential ... policy issue of the Journal of Law, Medicine ... experts with the Center for Medical Ethics and Health ... the tools to jumpstart this process. , Experts ...
Breaking Biology News(10 mins):Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 2Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 3Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 4Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 5Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 6Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 7Federal food program puts food on the table, but dietary quality could be improved 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... The MRSA 'superbug' evades many of the measures introduced ... organism found almost everywhere in hospital wards, according to ... Scientists from the University of Bath have shown that ... called Acanthamoeba polyphaga, which is ubiquitous in the environment ...
... cancers actually share something in common ?a molecular "signature" made ... that target key cancer genes and promote malignant growth. ... emerging class of gene regulators and may also pave the ... The study appears online in the Proceedings of the National ...
... discovered that some type of protective system goes into ... is deficient. This discovery indicates a hidden safety net ... the immune system such as AIDS. The Mayo Clinic-led ... and is reported in the early online edition of ...
Cached Biology News:MRSA use amoeba to spread, new research shows 2Common molecular 'signature' identified in solid tumors 2Common molecular 'signature' identified in solid tumors 3Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3
... is a new product number, created ... If showing no availability yet, please ... (Z71,487-9) or contact customer service for ... 100 mm, No. of sidearm 4 ...
... 15(S)-15-methyl PGF2α is a metabolically ... is a potent uterine stimulant ... administered intramuscularly to induce labor. ... serum progesterone concentrations when given ...
TGase3 (S-20)...
Amodiaquine...
Biology Products: